UBQLN4 (Ubiquilin-4, 1q21.3) was shown to regulate Wnt-β-catenin pathway activation in HCC cells22 and is associated with genomic instability and aggressive tumors23. Here, UBQLN4 is linked to hepatocellular carcinoma.